Citations

Showing 10 of 108119 citations.

Cutting Edge: HDAC3 Protects Double-Positive Thymocytes from P2X7 Receptor–Induced Cell Death
Philips, Rachael L. , McCue, Shaylene , Rajcula, Matthew, Shapiro, Virginia Smith , Shapiro, Virginia S

Mayo Clinic

The Journal of Immunology | January 9, 2019 | Volume: 202 | Issue: 4 | Pages: 1033-1038

10.4049/jimmunol.1801438 | PMID 30626694 Get It

Abstract Intricate life-versus-death decisions are programmed during T cell development, and the regulatory mechanisms that coordinate their activation and repression are still under investigation. In this study, HDAC3-deficient double-positive (DP) thymocytes exhibit a severe decrease in numbers. The thymic cortex is rich in ATP, which is released by macrophages that clear apoptotic DP thymocytes that fail to undergo positive selection. We demonstrate that HDAC3 is required to repress expression of the purinergic receptor P2X7 to prevent DP cell death. HDAC3-deficient DP thymocytes upregulate the P2X7 receptor, increasing sensitivity to ATP-induced cell death. P2rx7/HDAC3-double knockout mice show a partial rescue in DP cell number. HDAC3 directly binds to the P2rx7 enhancer, which is hyperacetylated in the absence of HDAC3. In addition, RORγt binds to the P2rx7 enhancer and promotes P2X7 receptor expression in the absence of HDAC3. Therefore, HDAC3 is a critical regulator of DP thymocyte survival and is required to suppress P2X7 receptor expression.
Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction
Anand, Atul , Shah, Anoop , Beshiri, Agim , Jaffe, Allan S. , Mills, Nicholas L. , Mills, Nicholas L , Jaffe, Allan S.

Mayo Clinic

Clinical Chemistry | January 9, 2019 | Volume: 65 | Issue: 3 | Pages: 484-489

10.1373/clinchem.2018.298059 | PMID 30626631 Get It

Abstract BACKGROUND The universal definition of myocardial infarction (UDMI) standardizes the approach to the diagnosis and management of myocardial infarction. High-sensitivity cardiac troponin testing is recommended because these assays have improved precision at low concentrations, but concerns over specificity may have limited their implementation. METHODS We undertook a global survey of 1902 medical centers in 23 countries evenly distributed across 5 continents to assess adoption of key recommendations from the UDMI. Respondents involved in the diagnosis and management of patients with suspected acute coronary syndrome completed a structured telephone questionnaire detailing the primary biomarker, diagnostic thresholds, and clinical pathways used to identify myocardial infarction. RESULTS Cardiac troponin was the primary diagnostic biomarker at 96% of surveyed sites. Only 41% of centers had adopted high-sensitivity assays, with wide variation from 7% in North America to 60% in Europe. Sites using high-sensitivity troponin more frequently used serial sampling pathways (91% vs 78%) and the 99th percentile diagnostic threshold (74% vs 66%) than sites using previous-generation assays. Furthermore, high-sensitivity institutions more often used earlier serial sampling (≤3 h) and accelerated diagnostic pathways. Fewer than 1 in 5 high-sensitivity sites had adopted sex-specific thresholds (18%). CONCLUSIONS There has been global progress toward the recommendations of the UDMI, particularly in the use of the 99th percentile diagnostic threshold and serial sampling. However, high-sensitivity assays are still used by a minority of sites, and sex-specific thresholds by even fewer. Additional efforts are required to improve risk stratification and diagnosis of patients with myocardial infarction.
Brazilian Perspective on Early Integration of Medical Students Interested in Plastic Surgery
Restrepo, David J. , Sisti, Andrea , Campos, Humberto , Saldanha, Osvaldo Ribeiro , Forte, Antonio J. , Forte, Antonio Jorge , Sisti, Andrea , Boczar, Daniel

Mayo Clinic

Annals of Plastic Surgery | January 9, 2019 | Volume: 82 | Issue: 2 | Pages: 131-132

10.1097/sap.0000000000001779 | PMID 30570568 Get It

Multiple myeloma and kidney transplantation: the beginning of a new era
bosch, Ines Van den, Sprangers, Ben , Gertz, Morie A.

Mayo Clinic

Clinical Kidney Journal | January 9, 2019 | Volume: 12 | Issue: 2 | Pages: 213-215

10.1093/ckj/sfz003 | PMID 30976398 Get It

Hodgkin lymphoma of the Maxillary Sinus: An Unusual Occurrence
Peterson, Jennifer , Hayostek, Cherie J., Garvey, Christopher, Menke, David M. , Rivera, Candido E., Peterson, Jennifer L.

Mayo Clinic

Ear, Nose & Throat Journal | January 9, 2019 | Volume: 91 | Issue: 1 | Pages: E16-E19

10.1177/014556131209100118 | PMID 22278873 Get It

The maxillary sinus is a rare anatomic site for Hodgkin lymphoma, as only 1 such case has been previously reported in the literature. Nevertheless, we recommend that lymphoma be considered in the differential diagnosis of a mass that involves the maxillary sinus or any other unusual extranodal site in the head and neck. Lymphoma in a patient who presents with disease in an unusual site and without lymphadenopathy is difficult to diagnose. We report the case of a 60-year-old woman who presented with nasal congestion and obstruction. Examination revealed an abnormal-appearing mucosa involving the maxillary sinus. Subsequent evaluation led to a diagnosis of Hodgkin lymphoma. Because making such a diagnosis is difficult, close attention to radiologic and pathologic findings is important. Our review of the literature revealed that treatment commonly includes chemotherapy and radiotherapy, which yield excellent outcomes. The current standard of care for patients with similar-stage Hodgkin lymphoma at other sites can guide the treatment course for patients with extranodal Hodgkin lymphoma.
Maxillary Sinus Angiomyolipoma: A Case Report and Overview
Weindling, Steven M. , Menke, David M. , Bolger, William E.

Mayo Clinic

Ear, Nose & Throat Journal | January 9, 2019 | Volume: 94 | Issue: 7 | Pages: E1-E4

10.1177/014556131509400713 | PMID 26214671 Get It

Otolaryngologists are called upon to evaluate and treat sinonasal masses discovered incidentally on imaging studies. Although common conditions such as sinonasal polyps and mucus retention cysts predominate, it is prudent practice to formulate a differential diagnosis to identify unusual conditions. We present a case of a maxillary sinus mass in a 78-year-old man that was discovered incidentally on brain imaging and subsequently identified on biopsy as an angiomyolipoma (AML). AMLs are benign hamartomatous tumors that rarely occur in extrarenal locations. Only a few cases have been reported in the nasal cavity. We believe our case represents the first reported instance of AML arising within a maxillary sinus. Identification of intratumoral fat within the mass on imaging studies may suggest the diagnosis of AML preoperatively. Close interdisciplinary collaboration among the otorhinolaryngology, radiology, and pathology services is beneficial for patient management. We report this case to raise awareness that AML can arise in this previously unreported location. Moreover, we wish to emphasize that AML should be considered in the differential diagnosis when imaging studies demonstrate a well-defined, heterogeneous, fat-containing solitary mass in the nasal cavity or maxillary sinus.
Septic Arthritis: A Unique Complication of Nasal Septal Abscess
Olsen, Steven M., Koch, Cody A., Ekbom, Dale C.

Mayo Clinic

Ear, Nose & Throat Journal | January 9, 2019 | Volume: 94 | Issue: 3 | Pages: E7-E19

10.1177/014556131509400303 | PMID 25738728 Get It

Nasal septal abscesses (NSAs) occur between the mucoperichondrium and the nasal septum. They most often arise when an untreated septal hematoma becomes infected. The most commonly reported sequela is a loss of septal cartilage support, which can result in a nasal deformity. Other sequelae include potentially life-threatening conditions such as meningitis, cavernous sinus thrombosis, brain abscess, and subarachnoid empyema. We report the case of a 17-year-old boy who developed an NSA after he had been struck in the face with a basketball. He presented to his primary care physician 5 days after the injury and again the next day, but his condition was not correctly diagnosed. Finally, 7 days after his injury, he presented to an emergency department with more serious symptoms, and he was correctly diagnosed with NSA. He was admitted to the intensive care unit, and he remained hospitalized for 6 days. Among the abscess sequelae he experienced was septic arthritis, which has heretofore not been reported as a complication of NSA. He responded well to appropriate treatment, although he lost a considerable amount of septal cartilage. He was discharged home on intravenous antibiotic therapy, and his condition improved. Reconstruction of the nasal septum will likely need to be pursued in the future.
Case Report: A Branchial Cleft Anomaly Presenting as an Oropharyngeal Mass
Mullin, David, Merz, M

Mayo Clinic

Ear, Nose & Throat Journal | January 9, 2019 | Volume: 90 | Issue: 12 | Pages: 581-583

10.1177/014556131109001208 | PMID 22180113 Get It

Branchial anomalies are common cervical pathologic entities encountered in the field of otolaryngology and are typical in the pediatric and young adult populations. In most cases, these anomalies present as a cyst, sinus, or fistula in a rather stereotypical fashion. When a branchial anomaly deviates from the classic presentation, an improper diagnosis and inadequate management are more likely to occur, leading to an increased recurrence rate. We present a case of a 6-year-old girl with an incidental finding of a right posterior oropharyngeal wall mass, distinctly separate from the tonsillar fossa, which was found on pathologic analysis to be a branchial cleft anomaly. The theories regarding the pathogenesis of branchial anomalies are presented, along with other cases of atypical branchial anomalies.
The Evolving Clinical Landscape for Dendritic Cell Vaccines and Cancer Immunotherapy
Cannon, Martin J. , Block, Matthew S. , Morehead, Lauren C. , Knutson, Keith L. , Knutson, Keith L.

Mayo Clinic

Immunotherapy | January 9, 2019 | Volume: 11 | Issue: 2 | Pages: 75-79

10.2217/imt-2018-0129 | PMID 30730268 Get It

Calcium sensing receptor in developing human airway smooth muscle
Roesler, A.M., Wicher, Sarah A. , Ravix, Jovanka, Britt, Rodney D. , Manlove, L., Teske, Jacob J. , Cummings, Katelyn, Farver, Carol , MacFarlane, Peter M. , Prakash, Y. S. , Roesler, Anne M, Manlove, Logan, Prakash, Y S , Teske, Jacob J , Thompson, Michael A. , Pabelick, Christina M.

Mayo Clinic

Journal of Cellular Physiology | January 9, 2019 | Volume: 234 | Issue: 8 | Pages: 14187-14197

10.1002/jcp.28115 | PMID 30624783 Get It

Abstract Airway smooth muscle (ASM) regulation of airway structure and contractility is critical in fetal/neonatal physiology in health and disease. Fetal lungs experience higher Ca 2+ environment that may impact extracellular Ca 2+ ([Ca 2+ ] o ) sensing receptor (CaSR). Well‐known in the parathyroid gland, CaSR is also expressed in late embryonic lung mesenchyme. Using cells from 18‐22 week human fetal lungs, we tested the hypothesis that CaSR regulates intracellular Ca 2+ ([Ca 2+ ] i ) in fetal ASM (fASM). Compared with adult ASM, CaSR expression was higher in fASM, while fluorescence Ca 2+ imaging showed that [Ca 2+ ] i was more sensitive to altered [Ca 2+ ] o . The fASM [Ca 2+ ] i responses to histamine were also more sensitive to [Ca 2+ ] o (0–2 mM) compared with an adult, enhanced by calcimimetic R568 but blunted by calcilytic NPS2143. [Ca 2+ ] i was enhanced by endogenous CaSR agonist spermine (again higher sensitivity compared with adult). Inhibition of phospholipase C (U73122; siRNA) or inositol 1,4,5‐triphosphate receptor (Xestospongin C) blunted [Ca 2+ ] o sensitivity and R568 effects. NPS2143 potentiated U73122 effects. Store‐operated Ca 2+ entry was potentiated by R568. Traction force microscopy showed responsiveness of fASM cellular contractility to [Ca 2+ ] o and NPS2143. Separately, fASM proliferation showed sensitivity to [Ca 2+ ] o and NPS2143. These results demonstrate functional CaSR in developing ASM that modulates airway contractility and proliferation.